1. Myers CS, Contreras MA, Chang MCJ, et al. Haloperidol downregulates phospholipase A(2)signaling in rat basal ganglia circuits BRAIN RES 896: (1-2) 96-101 MAR 30 2001
  2. Crawford CA, Zavala AR, Karper PE, et al. Long-term effects of postnatal amphetamine treatment on striatal protein kinase A activity, dopamine D-1-like and D-2-like binding sites, and dopamine content NEUROTOXICOL TERATOL 22: (6) 799-804 NOV-DEC 2000
  3. Crawford CA, Zavala AR, Karper PE, et al. Amphetamine treatment during the preweanling period produces enduring changes in striatal protein kinase a activity PHARMACOL BIOCHEM BE 66: (4) 835-840 AUG 2000 
  4. Murphy SJ, Liu T, Windfuhr M, et al. Altered ligand binding of D-1 and D-2 dopamine receptors in response to hypoxia and posthypoxic reoxygenation ADV EXP MED BIOL 471: 147-154 1999
  5. Geurts M, Hermans E, Maloteaux JM  Enhanced striatal dopamine D-2 receptor-induced [S-35]GTP gamma S binding after haloperidol treatment
    EUR J PHARMACOL 382: (2) 119-127 OCT 8 1999
  6. Geurts M, Hermans E, Cumps J, et al.  Dopamine receptor-modulated [S-35]GTP gamma S binding in striatum of 6-hydroxydopamine-lesioned rats BRAIN RES 841: (1-2) 135-142 SEP 11 1999 
  7. Geurts M, Hermans E, Maloteaux JM  Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [S-35]GTP gamma S binding LIFE SCI 65: (16) 1633-1645 SEP 10 1999
  8. Dewar KM, Paquet M, Sequeira A  Apparent dopamine D1 and D2 receptors in the weaver mutant mouse: receptor binding and coupling to adenylyl cyclase J NEURAL TRANSM 106: (5-6) 487-497 1999
  9. Piggott MA, Perry EK, Marshall EF, et al.  Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson's disease BIOL PSYCHIAT 44: (8) 765-774 OCT 15 1998
  10. Costa-Campos L, Lara DR, Nunes DS, et al.  Antipsychotic-like profile of alstonine PHARMACOL BIOCHEM BE 60: (1) 133-141 MAY 1998
  11.  Braun AR, Laruelle M, Mouradian MM  Interactions between D1 and D2 dopamine receptor family agonists and antagonists: The effects of chronic exposure on behavior and receptor binding in rats and their clinical implications J NEURAL TRANSM 104: (4-5) 341-362 1997
  12. Pennington SR  GTP-binding proteins .1. Heterotrimeric G proteins PROTEIN PROFILE 2: (3) 167-& 1995
  13. PENNINGTON SR GTP-BINDING PROTEINS - HETEROTRIMERIC G-PROTEINS PROTEIN PROFILE 1: (3) 169-342 1994
  14. GNEGY ME, AGRAWAL A, HEWLETT K, et al.  REPEATED HALOPERIDOL INCREASES BOTH CALMODULIN AND A CALMODULIN-BINDING PROTEIN IN RAT STRIATUM MOL BRAIN RES 27: (2) 195-204 DEC 1994
  15. MARCOTTE ER, SULLIVAN RM, MISHRA RK  STRIATAL G-PROTEINS - EFFECTS OF UNILATERAL 6-HYDROXYDOPAMINE LESIONS NEUROSCI LETT 169: (1-2) 195-198 MAR 14 1994
  16. SEE RE, CHAPMAN MA  THE CONSEQUENCES OF LONG-TERM ANTIPSYCHOTIC DRUG ADMINISTRATION ON BASAL GANGLIA NEURONAL FUNCTION IN LABORATORY-ANIMALS CRIT REV NEUROBIOL 8: (1-2) 85-124 1994
  17. WEISS B, ZHOU LW, ZHANG SP, et al.  ANTISENSE OLIGODEOXYNUCLEOTIDE INHIBITS D(2)-DOPAMINE RECEPTOR-MEDIATED BEHAVIOR AND D(2)-MESSENGER RNA NEUROSCIENCE 55: (3) 607-612 AUG 1993